Upcoming Webinar
Steal These 5 AI Grant Workflows, From Prospecting to Spend-Down.
Thu, Sep 17 @ 2PM ET
Why Instrumentl
Full Cycle Grant Platform
By Customer
Featured
$1.1m More Per Year
The Instrumentl Impact Report
Explore
Learn
Connect
Looking for Corporate grants for nonprofits in Missouri? Find the perfect grant for your nonprofit on Instrumentl.
10,000+
Available grants
$2.61B
Total funding
$5K
Median grant
Skip the search. Get matched with grants that fit your non-profit.
Smart recommendations based on your profile — in minutes.
Myasthenia Gravis Rare Disease Network (MGNet)
The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.
Diseases Studied
Myasthenia Gravis (MG) and its subtypes:
Goals, Mission, & Vision
The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:
Scholar Awards
Objectives
There is a critical need for investigators prepared to conduct clinical and translational research in myasthenia gravis (MG). The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.
Award Description
The MGNet Scholar Program provides mentored research training to prepare Scholars for an independent research career in the field of MG. The MGNet Scholar Program is 1 year in duration and selected Scholars receive up to $100,000 to support salary, research costs and didactics with potential for renewal. The program will provide an additional $3,000 to travel to MGNet sites to learn specific skills and/or to scientific meeting(s) to present the results of their research. If available for renewal, the program requires approval after interim report and is contingent on demonstration of adequate progress on the research and career development plan. Indirect costs are not allowed. Scholars are encouraged to transition to NIH (e.g., K award), departmental, or private foundation support for their research and further career development.Research must constitute at least 50% of each Scholar’s professional effort. Each Scholar must form a 2-3-member advisory committee to include a primary mentor, an additional clinician investigator or collaborator, and a MGNet faculty sponsor. The advisory committee will meet with the Scholar at least quarterly to review progress and each Scholar will develop an individual academic career development plan and renew it with the committee at least every 6 months.Myasthenia Gravis Rare Disease Network (MGNet)
The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.
Diseases Studied
Myasthenia Gravis (MG) and its subtypes:
Goals, Mission, & Vision
The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:
Pilot and Feasibility Grants
Objectives
MGNet, a NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Conquer MG, is seeking proposals for highly innovative investigations in early stages of development.
The priorities of the Pilot Grant Program are:
Pilot studies must be designed to access the resources of MGNet and focused on clinical and translational research, including fulfilling the definition of clinical and translational research and exclusion of animal studies.
Funding
The MGNet expects to fund up to two grants, each at a level of $75,000 (IDCs will be limited to 10% and included in the $75,000). Projects will be funded for 12 months. Selection among the applications received will be based on the recommendations of a review committee. A grant may be renewed for an additional one year with approval of interim report by the same review process and availability of funds. Demonstration of fulfillment of initial aims and justification for additional funding will be required. The request will be required a minimum of three months prior to the initial funding period completion.
The Retina Society, Inc.
The Retina Society was founded in 1968 exclusively for educational and scientific purposes concerning the diagnosis, care and treatment of diseases and injuries to the retina. The Retina Society began as an outgrowth of alumni meetings of Retina Associates, a retina practice founded in Boston in 1951 by Charles L. Schepens. Dr. Schepens is credited with establishing retina surgery as a sub-specialty.
Our mission is to reduce worldwide visual disability and blindness by promoting the education and professional interaction of vitreoretinal specialists, providing optimal care for patients with vitreoretinal diseases, and encouraging, through clinical and basic research, the discovery and development of new means to further patient care.
Retina Society Underrepresented in Medicine (RESOURCE) Mentoring Program
The Retina Society Underrepresented in Medicine (RESOURCE) Mentoring Program was created to engage and interest ophthalmology residents from underrepresented populations* in research and in pursuing careers in the retina subspecialty through dedicated mentoring exposure. The program will pair ophthalmology residents from underrepresented backgrounds with Retina Society mentors, with the goal of providing the residents with research and career mentorship.
*The American Association of Medical Colleges definition of underrepresented in medicine is: "Underrepresented in medicine means those racial and ethnic populations that are underrepresented in the medical profession relative to their numbers in the general population." We define the following groups as underrepresented: Black (African American or African), Latino/Hispanic, American Indian, Alaska Native, Native Hawaiian or Pacific Islander. We will also be considering applicants from LGBTQIA+ and socioeconomically underprivileged backgrounds.
Mentors will work with their designated mentees on research projects that will be presented at the Retina Society Annual Meeting in 2027 and submitted for publication consideration. Mentors and mentees will be acknowledged at the Retina Society Annual Meeting.
Looking for corporate grants for nonprofits in Missouri?
Read more about each grant below or start your 14-day free trial to see all corporate grants for nonprofits in Missouri recommended for your specific programs.
What's the typical amount funded for Missouri?
Grants are most commonly $101,542.
What's the total number of grants in Corporate Grants for Nonprofits in Missouri year over year?
In 2024, funders in Missouri awarded a total of 44,064 grants.
Among all the Corporate Grants for Nonprofits in Missouri given out in Missouri, the most popular focus areas that receive funding are Philanthropy, Voluntarism & Grantmaking Foundations, Education, and Human Services.
1. Philanthropy, Voluntarism & Grantmaking Foundations
2. Education
3. Human Services
How is funding for Corporate Grants for Nonprofits in Missouri changing over time?
Funding has increased by -15.61%.
How does grant funding vary by county?
St Louis County, Jackson County, and St Louis City receive the most funding.
| County | Total Grant Funding in 2024 |
|---|---|
| St Louis County | $2,185,711,864 |
| Jackson County | $1,234,679,326 |
| St Louis City | $1,054,441,922 |
| Greene County | $223,079,775 |
| Clay County | $178,423,081 |